On October 6, the Physicians Committee for Responsible Medicine urged the American College of Physicians to update its newly released clinical guidance. The medical nonprofit advocates prioritizing nutritional interventions, arguing that plant-based eating provides an equally effective menopause treatment alternative to hormone therapy without the associated health risks. This appeal directly addresses the recent ACP recommendations, which list hormonal interventions and various prescription medications as primary options despite their known side effects.
Dietary Efficacy Rivals Hormone Therapy
Recent clinical data suggests that nutritional shifts can match or exceed the 70 to 90 percent success rate of traditional hormone replacement. A 2022 clinical trial focusing on postmenopausal women found that an intervention eliminating animal products drastically improved vasomotor symptoms. By minimizing fat intake and incorporating a daily half-cup of cooked soybeans, participants experienced an 88 percent reduction in moderate to severe hot flashes over just 12 weeks.
Secondary Health Benefits
Beyond targeting primary vasomotor symptoms, the soy-rich vegan protocol yielded notable metabolic improvements not seen with standard pharmaceutical approaches. Women following the supervised nutrition plan shed an average of eight pounds during the three-month trial window. Participants also reported experiencing increased daytime energy and clearer skin, highlighting a stark contrast to the limited overall efficacy and frequent adverse reactions linked to the antidepressants and nerve-pain medications currently prioritized by the updated clinical guidelines.